7-(4-Bromobutoxy)-3,4-dihydro-2(1H)-quinolinone>98.0%(HPLC)(N)1g

(2R)-1-(2,4-Difluorophenyl)-2-((tetrahydro-2H-pyran-2-yl)oxy)propan-1-one, 97%, 1g

(2R,3S)-Methyl 3-benzamido-2-hydroxy-3-phenylpropanoate, 95.0%, 1g

(2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)pyridin-4-yl)boronic acid, 95+%, 100mg

(1Z)-N'-hydroxy-2-(1-propyl-4-piperidinyl)ethanimidamide, 95.0%, 5g

N-(4-methylbenzyl)-1-butanamine hydrochloride, 95.0%, 5g

4-Chlorophenylhydrazine Hydrochloride>98.0%(HPLC)(T)250g

Disodium 1,4-Butanedisulfonate>98.0%(T)10g

Benzophenoneimine, 98.0%, 25g

tert-butyl 3-iodo-7,7-dimethyl-2H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carboxylate, 98%, 250mg

Salirasib>96.0%(T)(HPLC)25mg

Iodure de potassium, min 99 %, pur, 500 g, emballage verre

N1,N1-Dipropylethane-1,2-diamine, 95.0%, 5g